- Group revenue growth up 23.9% to approx. EUR 44 million.
- Significant additional demand due to the pandemic leads to a revenue increase of up to 56.8% in some product groups
- More than 30 new employees hired in Production
- Medical technology manufacturer secures option right for existing premises
TRACOE medical records positive results for the 2020 financial year. The XTR Group, whose members include not only TRACOE medical Germany but also the UK sister company KAPITEX Healthcare Ltd, the Dutch subsidiary MC Europe B. V. and the Austrian TRACOE medical, significantly increased its total revenues by 23.9% to around EUR 44 million. Growth was almost as high for TRACOE medical Germany, with revenue growth up 21.4% on the previous year.
The specialist in medical devices and appliances for patients with a windpipe incision (tracheostomy), larynx removal (laryngectomy), and ventilation (respiratory care), headquartered in Nieder-Olm (Rhineland-Palatinate), alone generated around EUR 31 million of the total group revenue. The tremendous growth is not least also attributable to the particular circumstances of the exceptional year 2020: “The corona pandemic triggered a massive increase in the demand for respiratory aids worldwide, i.e., also for our products“, explained Managing Director Dr. Thomas Jurisch, who would certainly feel a lot happier if it were under different circumstances: “Due to this dreadfully serious situation, the demand was - and still is - so high that we recorded a 56.8% increase in revenue in the TRACOE percutan product group alone”.
Yet as regards growth, last year had even more substantial developments in store for TRACOE medical.
Internet Explorer ist ein veralteter Browser der von uns nicht mehr unterstützt wird. Bitte verwenden Sie einen aktuellen Browser, wie Microsoft Edge, Google Chrome oder Safari, für das beste Website-Erlebnis.